IRE produces first batch of LEU-based Mo-99
Belgium’s National Institute of Radioelements (IRE) announced on April 30 that it has produced its first batch of commercial molybdenum-99 from low-enriched uranium (LEU) targets. The first batch of Mo-99, whose decay product, technetium-99m, is used in nuclear medicine for diagnostic imaging, was produced for the U.S. health market. IRE said that the conversion to LEU represents a key milestone for the institute in the global commitment to end the civilian use of highly enriched uranium (HEU) for the production of Mo-99.
-3 2x1.jpg)
The latest season of 
The ANS Young Members Group (YMG) is offering a series of live webinars—Spotlight on National Labs—to highlight the missions, key projects, and rising stars of the Department of Energy’s national laboratories. Recently it was Argonne National Laboratory’s turn to shine.